Modulation of cellular gene expression in B lymphoma cells following in vitro infection by Epstein-Barr virus (EBV)
- PMID: 1698730
- DOI: 10.1002/ijc.2910460418
Modulation of cellular gene expression in B lymphoma cells following in vitro infection by Epstein-Barr virus (EBV)
Abstract
In vitro infection of EBV-negative lymphoma cell lines with immortalizing strains of Epstein-Barr virus induces the cell-surface expression of B-cell markers, such as the EBV receptor/CR2 (CD21) and the CD23 antigen. The non-immortalizing EBV variant, P3HRI, which carries a deletion encompassing the EBV nuclear antigen 2 (EBNA2) gene, fails to induce any such expression. We show here that the EBV-mediated up-regulation of cell-surface expression of these molecules is associated with an increased level of the specific steady-state RNA corresponding to these 2 genes. These results suggest that the role of EBNA2 in B-cell growth and immortalization may be related to its role in transactivation of cellular genes. In order to identify other cellular genes whose expression may be modulated by EBV, we analyzed the level of transcription of a set of genes possibly involved in Burkitt's lymphoma pathogenesis. The level of the c-myc oncogene transcript was not significantly affected by in vitro EBV infection. The c-fgr oncogene, thought to be specifically activated in EBV-infected cells, was found to be expressed in some EBV-negative lymphoma cells and also to be activated by both non-immortalizing and immortalizing strains of EBV. The expression of vimentin, the major 56-kDa polypeptide of mesenchymal cell intermediate filaments, was altered by all EBV isolates, in either a negative or a positive way, depending on the cell line. Expression of lymphocyte-function-associated antigens, LFA-1 alpha/beta (CD11 a/18) and LFA-3 (CD58), involved in intercellular adhesion and the T-cytotoxic pathway, were differentially regulated by EBV; a crucial observation was the activation by immortalizing EBV isolates of LFA-1 beta chain (CD18) and of LFA-3 (CD58). The EBV-and possibly EBNA2-associated modulation of cellular genes, such as CR2 (CD21), CD23 and LFAs, probably represents key events for EBV-induced B-cell proliferation, and also for in vivo immune control of EBV-infected B cells.
Similar articles
-
Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.J Virol. 1990 Mar;64(3):1002-13. doi: 10.1128/JVI.64.3.1002-1013.1990. J Virol. 1990. PMID: 2154588 Free PMC article.
-
Low expression of lymphocyte function-associated antigen (LFA)-1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus.Blood. 1990 May 1;75(9):1827-33. Blood. 1990. PMID: 1691936
-
Epstein-Barr virus (EBV) nuclear-antigen-2-induced up-regulation of CD21 and CD23 molecules is dependent on a permissive cellular context.Int J Cancer. 1993 Jan 2;53(1):153-60. doi: 10.1002/ijc.2910530128. Int J Cancer. 1993. PMID: 8416201
-
EBNA2 and c-myc in B cell immortalization by Epstein-Barr virus and in the pathogenesis of Burkitt's lymphoma.Curr Top Microbiol Immunol. 1999;246:315-20; discussion 321. doi: 10.1007/978-3-642-60162-0_39. Curr Top Microbiol Immunol. 1999. PMID: 10396071 Review. No abstract available.
-
The ubiquitin/proteasome system in Epstein-Barr virus latency and associated malignancies.Semin Cancer Biol. 2003 Feb;13(1):69-76. doi: 10.1016/s1044-579x(02)00101-3. Semin Cancer Biol. 2003. PMID: 12507558 Review.
Cited by
-
Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming.PLoS Pathog. 2013 Sep;9(9):e1003636. doi: 10.1371/journal.ppat.1003636. Epub 2013 Sep 12. PLoS Pathog. 2013. PMID: 24068937 Free PMC article.
-
A central role for Fos in human B- and T-cell NFAT (nuclear factor of activated T cells): an acidic region is required for in vitro assembly.Mol Cell Biol. 1994 Oct;14(10):6886-95. doi: 10.1128/mcb.14.10.6886-6895.1994. Mol Cell Biol. 1994. PMID: 7935406 Free PMC article.
-
Epstein-Barr Virus Latent Membrane Protein-1 Induces the Expression of SUMO-1 and SUMO-2/3 in LMP1-positive Lymphomas and Cells.Sci Rep. 2019 Jan 18;9(1):208. doi: 10.1038/s41598-018-36312-4. Sci Rep. 2019. PMID: 30659232 Free PMC article.
-
The Epstein-Barr Virus Oncoprotein, LMP1, Regulates the Function of SENP2, a SUMO-protease.Sci Rep. 2019 Jul 2;9(1):9523. doi: 10.1038/s41598-019-45825-5. Sci Rep. 2019. PMID: 31266997 Free PMC article.
-
LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.J Virol. 2015 Aug;89(15):7465-77. doi: 10.1128/JVI.00711-15. Epub 2015 May 6. J Virol. 2015. PMID: 25948750 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous